11.1 Stroke Pathophysiology, Vascular Syndromes & Motor Assessment

11.1 Stroke Pathophysiology, Vascular Syndromes & Motor Assessment

[!NOTE] DHA Clinical Competency Core: Cerebrovascular accidents (CVAs) represent one of the primary drivers of inpatient neurorehabilitation admissions across Dubai Health Authority (DHA) facilities. On the DHA Physiotherapist licensing examination (PHY5121), candidates are rigorously tested on the neuroanatomical localization of stroke syndromes, hemodynamic emergency management windows, differentiation between cortical and lacunar deficits, Brunnstrom staging of motor recovery, and the objective differentiation of velocity-dependent spasticity from passive mechanical contracture.

Stroke, or cerebrovascular accident (CVA), is defined by the World Health Organization as a rapidly developing clinical syndrome of focal (or global) disturbance of cerebral function lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin. Successful neurological rehabilitation requires an exacting grasp of cerebral vascular anatomy, cellular ischemic cascades, and the neurophysiological stages of motor recovery.

---

1. Stroke Pathophysiology & Revascularization Windows

Cerebrovascular accidents are broadly categorized into two major pathological classes: ischemic (~85% of cases) and hemorrhagic (~15% of cases).

                                [ CEREBROVASCULAR ACCIDENT (CVA) ]
                                                │
                        ┌───────────────────────┴───────────────────────┐
                        ▼                                               ▼
           [ Ischemic Stroke (~85%) ]                      [ Hemorrhagic Stroke (~15%) ]
           • Thrombotic: Large vessel atheroma             • Intracerebral Hemorrhage (ICH, ~10%):
           • Cardioembolic: Atrial fibrillation, mural       Rupture of Charcot-Bouchard microaneurysms
             thrombi (abrupt, maximal at onset)              in deep lenticulostriate/thalamic vessels
           • Lacunar: Small vessel lipohyalinosis          • Subarachnoid Hemorrhage (SAH, ~5%):
             (pure motor, pure sensory, no cortical signs)   Rupture of saccular/berry aneurysms

Ischemic Stroke Subtypes

1. Thrombotic Stroke: Typically results from progressive atherosclerotic plaque ulceration and local platelet thrombus formation in large cerebral arteries (e.g., internal carotid artery, origin of the middle cerebral artery, or basilar artery). Onset is often stuttering or stepwise and frequently preceded by transient ischemic attacks (TIAs).
2. Cardioembolic Stroke: Results from a travelling embolus originating in the heart (e.g., secondary to non-valvular atrial fibrillation, recent myocardial infarction with mural thrombus, prosthetic cardiac valves, or patent foramen ovale). Characterized by sudden, abrupt neurological onset with maximal deficits present at the very beginning.
3. Lacunar Stroke (Small Vessel Occlusion): Accounts for ~20% of ischemic strokes. Involves occlusion of small, deep penetrating end-arteries (50–400 μm diameter), such as the lenticulostriate branches of the MCA or thalamoperforating branches of the PCA. The primary vascular pathology is lipohyalinosis and microatheroma secondary to chronic hypertension and diabetes mellitus. Infarctions are small (<1.5 cm diameter) and localized to the internal capsule, basal ganglia, thalamus, or basis pontis.
   • Hallmark Clinical Feature: Classic lacunar syndromes produce isolated focal deficits without cortical signs. Patients do not exhibit aphasia, visual field cuts, neglect, or cognitive impairment. The 5 classical lacunar syndromes include: Pure Motor Hemiparesis (posterior limb of internal capsule), Pure Sensory Stroke (ventral posterolateral nucleus of thalamus), Ataxic Hemiparesis (basis pontis or corona radiata), Dysarthria-Clumsy Hand Syndrome (genu of internal capsule or upper pons), and Sensorimotor Stroke (thalamocapsular junction).

Hemorrhagic Stroke Subtypes

1. Intracerebral Hemorrhage (ICH): Bleeding directly into the brain parenchyma, most commonly from the rupture of tiny Charcot-Bouchard microaneurysms on penetrating arterioles damaged by chronic arterial hypertension. Common anatomical sites: putamen/basal ganglia (50%), thalamus (15%), pons (10%), and cerebellum (10%). Manifests with severe headache, vomiting, progressive neurological decline over minutes to hours, and signs of elevated intracranial pressure.
2. Subarachnoid Hemorrhage (SAH): Bleeding into the subarachnoid space, classically caused by rupture of a saccular (berry) aneurysm at bifurcations of the Circle of Willis (e.g., anterior communicating artery). Presents classically as a catastrophic "thunderclap headache" ("worst headache of my life") accompanied by neck stiffness, photophobia, and altered consciousness without initial focal limb paralysis.

The Ischemic Penumbra & Thrombolytic Time Windows

During an acute ischemic stroke, cerebral blood flow (CBF; normal ~50 mL/100g/min) drops precipitously:

• Ischemic Core: Areas where CBF drops below 10–12 mL/100g/min. Cellular bioenergetic failure occurs within minutes; membrane ATP pumps cease, toxic calcium influx triggers terminal apoptosis and necrosis. Tissue in the core is irreversibly infarcted.
• Ischemic Penumbra: Surrounding rim of tissue hypoperfused at 12–22 mL/100g/min. Penumbral neurons undergo electrical silence (preventing normal synaptic signaling and producing clinical deficits) but maintain basic structural integrity and metabolic viability for several hours via collateral microvascular circulation.
• Therapeutic Time Windows:
  • Intravenous rtPA (Alteplase / Tenecteplase): Must be administered within <4.5 hours from the patient's "last known normal" (time of symptom onset). Inclusion requires confirmed ischemic stroke on non-contrast CT (excluding hemorrhage), systolic BP <185 mmHg and diastolic BP <110 mmHg, normal platelet count (>100,000/μL), and absence of recent major trauma, surgery, or active internal bleeding.
  • Mechanical Endovascular Thrombectomy (EVT): Indicated for acute large vessel occlusions (LVO) of the anterior circulation (internal carotid artery or proximal M1 segment of MCA). The standard EVT window is up to 6 hours from onset, but can be extended up to 24 hours in selected patients demonstrating a significant clinical-core mismatch on perfusion CT or diffusion MRI (DAWN and DEFUSE-3 criteria).

---

2. Vascular Stroke Syndromes: Cerebral & Brainstem Territories

Accurate lesion localization is founded on matching physical examination findings to the territory of the occluded cerebral or brainstem artery.

+---------------------------------------------------------------------------------------------------+
|                             Cerebral Artery Territory Deficit Patterns                             |
+---------------------------------------------------------------------------------------------------+
| Artery Territory        | Motor / Sensory Distribution     | Cortical / Neuropsychological Features |
+-------------------------+----------------------------------+----------------------------------------+
| Middle Cerebral Artery  | Contralateral hemiparesis and    | Dominant: Broca or Wernicke aphasia    |
| (MCA) - Main Trunk      | hemisensory loss:                | Non-dominant: Hemispatial neglect,     |
|                         | Face & Arm > Leg (UE > LE)       | anosognosia, visuospatial distortion   |
+-------------------------+----------------------------------+----------------------------------------+
| Anterior Cerebral Artery| Contralateral hemiparesis and    | Abulia, apathy, motor perseveration,   |
| (ACA)                   | hemisensory loss:                | urinary incontinence (paracentral),    |
|                         | Leg > Arm & Face (LE > UE/face)  | contralateral grasp reflex             |
+-------------------------+----------------------------------+----------------------------------------+
| Posterior Cerebral Artery| Contralateral sensory loss,     | Homonymous hemianopia (macular sparing)|
| (PCA)                   | mild transient hemiparesis,      | Visual agnosia, prosopagnosia, alexia  |
|                         | Central thalamic pain syndrome   | without agraphia, memory deficits      |
+-------------------------+----------------------------------+----------------------------------------+

Middle Cerebral Artery (MCA) Syndrome

The MCA is the most common site of cerebral infarction. It supplies the vast lateral convexity of the frontal, parietal, and temporal lobes, as well as the posterior limb of the internal capsule via the lenticulostriate branches:

• Motor & Sensory Homunculus Deficits: The lateral cerebral cortex maps the face, mouth, and upper extremity. Hence, MCA infarction causes contralateral hemiplegia and hemisensory loss with face and upper extremity much more severely impaired than the lower extremity (Face/UE > LE).
• Visual Deficits: Contralateral homonymous hemianopia or inferior quadrantanopia due to damage to the optic radiations traveling through the internal capsule and temporal/parietal lobes.
• Dominant Hemisphere (Usually Left Hemisphere):
  • Broca Aphasia (Expressive): Occlusion of the superior division of MCA (inferior frontal gyrus, Brodmann areas 44/45). Characterized by non-fluent, effortful, halting speech, agrammatism, but relatively preserved auditory comprehension. The patient is frustrated because they retain insight into their expressive deficit.
  • Wernicke Aphasia (Receptive): Occlusion of the inferior division of MCA (posterior superior temporal gyrus, Brodmann area 22). Characterized by fluent, effortless speech that is paraphasic and devoid of content ("word salad"), severely impaired auditory comprehension, and lack of awareness of the deficit (anosognosia).
  • Global Aphasia: Occlusion of the MCA mainstem affecting both divisions; severe impairment in both expression and comprehension.
  • Bilateral Apraxia: Ideomotor and ideational apraxia resulting from left parietal damage.
• Non-Dominant Hemisphere (Usually Right Hemisphere):
  • Unilateral Spatial Neglect (USN): Profound inattention to the contralateral (left) hemispace.
  • Anosognosia: Frank denial or total lack of awareness of the hemiplegic limb and its functional deficits.
  • Visuospatial and Perceptual Deficits: Loss of depth perception, spatial disorientation, and impaired body schema.

Anterior Cerebral Artery (ACA) Syndrome

The ACA supplies the medial surface of the frontal and parietal lobes, the anterior four-fifths of the corpus callosum, and the paracentral lobule:

• Motor & Sensory Deficits: The medial cortex homunculus represents the lower extremity and perineum. ACA infarction leads to contralateral hemiparesis and hemisensory loss predominantly affecting the lower extremity, with minimal or no involvement of the upper extremity or face (LE > UE/face).
• Paracentral Lobule Involvement: Causes loss of voluntary sphincter control, resulting in urinary incontinence.
• Frontal Lobe Cognitive & Behavioral Signs:
  • Abulia & Apathy: Psychomotor slowing, severe lack of motivation or spontaneous initiative, delayed responses, and emotional flatlining.
  • Akinetic Mutism: Patient is alert but completely silent and immobile in extensive bilateral frontal lesions.
  • Primitive Frontal Release Reflexes: Re-emergence of the contralateral grasp reflex, rooting reflex, and sucking reflex.
  • Alien Hand Syndrome: Involuntary, autonomous, complex goal-directed movements of the contralateral hand (e.g., unbuttoning a shirt that the other hand is buttoning), secondary to anterior corpus callosum infarction.

Posterior Cerebral Artery (PCA) Syndrome

The PCA supplies the occipital lobe, inferomedial temporal lobe, posterior thalamus, and midbrain:

• Visual Deficits: Contralateral homonymous hemianopia with macular sparing. The macula (central vision) is spared because the occipital pole receives dual collateral blood supply from the terminal branches of the middle cerebral artery.
• Cortical Visual Syndromes: Visual agnosia (inability to recognize familiar objects), prosopagnosia (inability to recognize familiar faces), and alexia without agraphia (inability to read despite preserved ability to write, occurring with dominant PCA infarction affecting the left splenium of the corpus callosum and left occipital cortex).
• Central Post-Stroke Pain Syndrome (Dejerine-Roussy Syndrome): Infarction of the ventral posterolateral (VPL) nucleus of the thalamus produces severe, persistent, intractable burning pain, hyperalgesia, and allodynia (pain provoked by innocuous light touch or clothing contact) across the contralateral hemibody, typically appearing weeks to months post-infarction.

Vertebrobasilar & Brainstem Stroke Syndromes

Brainstem infarctions produce characteristic "crossed syndromes"—ipsilateral cranial nerve deficits combined with contralateral body motor or sensory tracts deficits.

+---------------------------------------------------------------------------------------------------+
|                              Key Brainstem Stroke Syndromes Comparison                            |
+---------------------------------------------------------------------------------------------------+
| Syndrome                | Vascular Occlusion | Key Clinical Hallmarks                                     |
+-------------------------+--------------------+------------------------------------------------------------+
| Lateral Medullary       | PICA or Vertebral  | • Nucleus ambiguus: Dysphagia, dysarthria, hoarseness      |
| (Wallenberg) Syndrome   | Artery             | • Trigeminal tract: Ipsilateral facial pain/temp loss      |
|                         |                    | • Spinothalamic tract: Contralateral body pain/temp loss   |
|                         |                    | • Sympathetic fibers: Ipsilateral Horner syndrome          |
|                         |                    | • Vestibular nuclei: Vertigo, nystagmus; Ataxia (restiform)|
|                         |                    | • NO MOTOR WEAKNESS IN LIMBS!                              |
+-------------------------+--------------------+------------------------------------------------------------+
| Locked-In Syndrome      | Basilar Artery     | • Bilateral ventral pons infarction                        |
|                         | (Pontine branches) | • Quadriplegia & anarthria (corticospinal/corticobulbar)   |
|                         |                    | • Intact vertical eye movements & upper eyelid blinking    |
|                         |                    | • Consciousness & higher cognition 100% PRESERVED          |
+-------------------------+--------------------+------------------------------------------------------------+
| Weber Syndrome          | Paramedian Midbrain| • Ipsilateral oculomotor (CN III) palsy: ptosis, mydriasis |
| (Ventral Midbrain)      | branches of PCA    | • Contralateral spastic hemiplegia (cerebral peduncle)     |
+-------------------------+--------------------+------------------------------------------------------------+

• Lateral Medullary (Wallenberg) Syndrome:
  • Vascular Cause: Occlusion of the Posterior Inferior Cerebellar Artery (PICA) or its parent vertebral artery.
  • Structures Involved & Manifestations:
    1. Nucleus Ambiguus (CN IX, X): Dysphagia (difficulty swallowing), dysarthria, hoarseness, and loss of the ipsilateral gag reflex.
    2. Spinal Trigeminal Nucleus & Tract: Ipsilateral loss of pain and temperature sensation over the face.
    3. Spinothalamic Tract: Contralateral loss of pain and temperature sensation over the trunk and limbs.
    4. Descending Sympathetic Tract: Ipsilateral Horner syndrome (triad of ptosis, miosis, and facial anhidrosis).
    5. Vestibular Nuclei: Severe vertigo, nausea, vomiting, and intractable horizontal/rotatory nystagmus.
    6. Inferior Cerebellar Peduncle (Restiform Body): Ipsilateral limb and gait ataxia.
  • Crucial Physical Therapy Note: There is no extremity motor paralysis because the medullary pyramids (corticospinal tracts) sit ventrally and are supplied by the anterior spinal artery.
• Locked-In Syndrome:
  • Vascular Cause: Thrombosis of the basilar artery, causing extensive infarction of the bilateral ventral pons.
  • Clinical Manifestation: Bilateral disruption of the descending corticospinal and corticobulbar tracts leaves the patient with total quadriplegia, anarthria (mutism), and aphagia. However, the reticular activating system in the dorsal tegmentum is spared, meaning consciousness and higher cortical cognition remain fully preserved. Sparing of the rostral midbrain oculomotor nuclei (CN III and IV) preserves voluntary vertical eye movements and upper eyelid blinking, which serve as the sole communication conduit.

---

3. Motor Assessment: Brunnstrom Recovery Stages & Synergy Patterns

Following upper motor neuron (UMN) injury from a stroke, motor recovery rarely proceeds in random isolated movements. Dr. Signe Brunnstrom demonstrated that motor recovery typically progresses through a stereotypic hierarchical continuum from flaccidity to isolated coordinated movement.

                                [ BRUNNSTROM'S 6 STAGES OF MOTOR RECOVERY ]
                                                     │
         ┌──────────┬──────────┬─────────────┼─────────────┬────────────┬──────────┐
         ▼          ▼          ▼             ▼             ▼            ▼          ▼
     [Stage 1]  [Stage 2]  [Stage 3]     [Stage 4]     [Stage 5]    [Stage 6]  [Stage 7]
     Flaccid    Synergies  Voluntary     Movement out  Complex out  Isolated   Normal
     No tone    emerging   synergy peak  of synergy    of synergy   joint      functional
     or reflex  spasticity Spasticity    begins; tone  dominates;   movement;  speed and
     activity   developing at maximum    declines      tone normal  speed near coordination
                                                                    normal

Brunnstrom's 6 Stages of Motor Recovery Defined

1. Stage 1 (Flaccidity): Immediately following acute stroke (cerebral shock). Total absence of voluntary movement and flaccidity of the paretic limbs. Deep tendon reflexes (DTRs) are hypoactive or completely absent.
2. Stage 2 (Emergence of Spasticity & Synergies): Basic movement synergies or minimal voluntary components begin to appear, often elicited only as associated reactions (involuntary movement of the paretic limb triggered by resisted movement or coughing). Spasticity begins to develop as mild resistance to passive stretch.
3. Stage 3 (Voluntary Synergy Control & Peak Spasticity): The patient gains voluntary control over the basic movement synergies, able to initiate and complete full synergy movements. However, movement is strictly bound within synergy; the patient cannot perform any movement deviating from the synergy pattern. Spasticity reaches its clinical climax/peak.
4. Stage 4 (Movement Combinations Deviating from Synergy): Spasticity begins to decline. The patient successfully executes specific movement combinations that break out of the dominant synergy:
   • Upper Extremity: (1) Placing the hand behind the lumbar spine, (2) forward shoulder elevation to 90° with the elbow fully extended, and (3) pronation/supination with the elbow flexed to 90°.
   • Lower Extremity: (1) Unweighted knee flexion beyond 90° in sitting with the foot sliding backward on the floor, and (2) active isolated ankle dorsiflexion in sitting with the heel maintained on the floor.
5. Stage 5 (Complex Combinations Relative to Synergies): Synergies lose their dominant hold; spasticity continues to diminish. The patient performs more demanding out-of-synergy combinations:
   • Upper Extremity: (1) Shoulder abduction to 90° with elbow fully extended, (2) overhead shoulder flexion beyond 90° with elbow extended, and (3) forearm pronation/supination with the elbow fully extended.
   • Lower Extremity: (1) Isolated knee flexion in standing with hip extended, and (2) isolated ankle dorsiflexion in standing with knee extended and foot off the floor.
6. Stage 6 (Normal Coordination & Isolated Movements): Spasticity is essentially absent. Isolated, individual joint movements are executed smoothly with near-normal coordination, velocity, and dexterity. Rapid alternating movements (dysdiadochokinesia testing) approach normal performance.

Stereotypical Synergy Patterns

A limb synergy is a stereotyped mass pattern of movement in which activation of one muscle group involuntarily recruits all other anatomically linked muscles within that synergy.

+---------------------------------------------------------------------------------------------------+
|                          Stereotypical Stroke Synergy Patterns Breakdown                          |
+---------------------------------------------------------------------------------------------------+
| Synergy Component       | Upper Extremity (UE)             | Lower Extremity (LE)                 |
+-------------------------+----------------------------------+--------------------------------------+
| FLEXION SYNERGY         | • Scapula: Retraction, elevation | • Hip: Flexion (*strongest*),        |
|                         | • Shoulder: Abduction, ext. rot. |   abduction, external rotation       |
|                         | • Elbow: Flexion (*strongest*)   | • Knee: Flexion                      |
|                         | • Forearm: Supination            | • Ankle: Dorsiflexion, inversion     |
|                         | • Wrist/Fingers: Flexion         | • Toes: Extension (dorsiflexion)     |
+-------------------------+----------------------------------+--------------------------------------+
| EXTENSION SYNERGY       | • Scapula: Protraction, depress. | • Hip: Extension, adduction, int. rot|
|                         | • Shoulder: Adduction, int. rot. | • Knee: Extension (*strongest*)      |
|                         | • Elbow: Extension               | • Ankle: Plantarflexion (*strongest*),|
|                         | • Forearm: Pronation (*strongest*)|   inversion                          |
|                         | • Wrist/Fingers: Flexion         | • Toes: Flexion (plantarflexion)     |
+-------------------------+----------------------------------+--------------------------------------+
| Dominant Pattern Seen   | **FLEXION SYNERGY DOMINATES**    | **EXTENSION SYNERGY DOMINATES**      |
| in Resting Hemiplegia   | (Retracted scapula, flexed elbow,| (Extended knee, equinovarus ankle,   |
|                         | pronated/supinated, curled hand) | adducted hip, toe-drag gait)         |
+-------------------------+----------------------------------+--------------------------------------+

---

4. Clinical Measurement of Spasticity: MAS vs. Tardieu Scales

Spasticity is a motor disorder characterized by a velocity-dependent increase in tonic stretch reflexes (muscle tone) with exaggerated tendon jerks, resulting from hyperexcitability of the stretch reflex arc (Lance, 1980).

The Modified Ashworth Scale (MAS)

The Modified Ashworth Scale assesses resistance encountered during passive manual elongation of a relaxed muscle group moved through its full physiological range of motion at a moderate speed (approximately one second per stretch cycle):

• Grade 0: No increase in muscle tone.
• Grade 1: Slight increase in muscle tone, manifested by a catch and release OR by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension.
• Grade 1+: Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM.
• Grade 2: More marked increase in muscle tone through most of the ROM, but affected part(s) easily moved.
• Grade 3: Considerable increase in muscle tone, passive movement difficult.
• Grade 4: Affected part(s) rigid in flexion or extension.

[!CAUTION] Critical Limitations of the MAS: The MAS does not test at multiple velocities and cannot differentiate between neural spasticity (hyper-reflexia) and non-neural biomechanical changes (viscoelastic stiffness, muscle shortening, and capsular contracture). This often leads to over-prescribing antispastic medications for what is actually fixed contracture.

The Tardieu Scale: Gold Standard for Velocity-Dependent Spasticity

The Tardieu Scale overcomes MAS limitations by measuring muscle resistance at specified, controlled velocities, systematically separating neural spasticity from mechanical muscle contracture.

Testing Velocities ($V$)

• $V_1$: As slow as possible (slower than the natural stretch reflex threshold; evaluates passive mechanical joint range).
• $V_2$: Speed of the limb falling under the acceleration of gravity.
• $V_3$: Moved as fast as possible (faster than the stretch reflex threshold; elicits dynamic spastic catch).

Parameters Measured

1. Quality of Muscle Reaction ($X$ score, 0 to 4):
   • 0: No resistance throughout passive movement.
   • 1: Slight resistance throughout, with no clear catch.
   • 2: Clear catch at a precise angle, interrupting passive movement, followed by release.
   • 3: Fatigable clonus (<10 seconds) occurring at a precise angle.
   • 4: Unfatigable clonus (>10 seconds) occurring at a precise angle.
2. Angle of Muscle Reaction ($Y$ angle in degrees):
   • $R_2$ (Passive Range Angle): Full passive ROM achieved when moving the limb slowly at $V_1$.
   • $R_1$ (Angle of Catch): The angle at which the velocity-dependent catch or clonus first appears when moving the limb rapidly at $V_3$.

Clinical Interpretation of the Dynamic Spasticity Angle ($R_2 - R_1$)

• Large $R_2 - R_1$ Difference: Indicates a substantial dynamic neural spasticity component. The muscle possesses good underlying anatomical length ($R_2$), but is abruptly arrested during fast movements by hyperactive stretch reflexes ($R_1$). Clinical Action: High likelihood of functional benefit from focal neurotoxin (Botulinum Toxin Type A) injections, intrathecal baclofen, and active reciprocal motor re-education.
• Small $R_2 - R_1$ Difference ($R_2 \approx R_1$): Indicates a predominant fixed structural muscle/joint contracture. The catch occurs at or near the end of available anatomical range regardless of velocity. Clinical Action: Botulinum toxin will have minimal functional benefit; treatment must prioritize mechanical tissue lengthening (serial casting, sustained static progressive splinting, high-load long-duration positioning, or surgical tendon lengthening).

---

5. Clinical Scenarios & DHA Exam Traps

Clinical Scenario: Staging & Spasticity Differential Diagnosis

Scenario: A 61-year-old male with a right Middle Cerebral Artery ischemic stroke 8 weeks ago presents for rehabilitation. On physical examination of the left upper extremity, the patient can voluntarily flex his shoulder to 90° while holding his elbow locked in full extension. However, when asked to abduct his shoulder to 90° in the frontal plane with an extended elbow, his elbow involuntarily flexes and his forearm supinates into a strong flexor synergy. Resistance testing of the left elbow flexors moved at moderate speed shows a catch followed by minimal resistance through the first third of the remaining extension range. Testing with the Tardieu scale reveals a slow passive extension ($R_2$) of 0° (full extension), but a rapid stretch catch ($R_1$) occurs at -45° of extension ($R_2 - R_1 = 45°$).

Clinical Decision & Analysis:

1. Brunnstrom Stage: The patient is in Brunnstrom Stage 4. Achieving shoulder forward flexion to 90° with the elbow extended is one of the three hallmark criteria of Stage 4. He has not yet reached Stage 5 because shoulder abduction to 90° with an extended elbow is still dominated by the flexor synergy.
2. Spasticity Grading: The elbow flexor tone corresponds to MAS Grade 1+ (catch followed by minimal resistance through less than half the remaining ROM).
3. Tardieu Interpretation: The substantial difference of 45° between $R_2$ and $R_1$ confirms profound dynamic neural spasticity with completely preserved underlying muscle length. The patient is an ideal candidate for focal botulinum toxin injection to the biceps and brachialis, followed immediately by targeted active triceps extension training.

DHA Exam Traps to Master

[!WARNING] DHA Exam Trap 1: Confusing MAS 1 and MAS 1+

• Trap: Assuming that any "catch and release" qualifies as Grade 1+.
• Fact: Grade 1 involves a catch and release or minimal resistance occurring strictly at the end of range. Grade 1+ requires a catch followed by minimal resistance that persists through less than half the remaining ROM.

DHA Exam Trap 2: Hemiparesis Distribution in MCA vs ACA

• Trap: Assuming all strokes affect the arm and leg equally.
• Fact: MCA affects the Face and Upper Extremity significantly more than the Lower Extremity (UE/Face > LE). ACA affects the Lower Extremity significantly more than the Upper Extremity (LE > UE/Face). If an exam question describes a patient with dense leg weakness, urinary incontinence, and normal arm strength, the occluded artery is strictly ACA, never MCA.

DHA Exam Trap 3: Wallenberg Syndrome Motor Presentation

• Trap: Selecting "contralateral hemiparesis" as a sign of lateral medullary (PICA) infarction.
• Fact: Wallenberg syndrome causes NO limb motor paralysis. The corticospinal pyramids are located ventrally in the medulla and receive perfusion from the anterior spinal artery, entirely sparing limb strength.